Results 151 to 160 of about 12,049 (277)

Long-Term Effects of Ketoconazole in the Treatment of Residual or Recurrent Cushing's Disease.

, 2000
S. T. Chou, Jen‐Der Lin
openalex   +2 more sources

Memory impairment in Cushing's disease [PDF]

, 2009
M. Mauri, Elena Sinforiani, G. Bono, Federico Vignati, Maria Elisa Berselli, Roberto Attanasio, Giuseppe Nappi   +6 more
openalex   +1 more source

Physiological and Perceived Stress, Anxiety, Depression and Burnout Among ICU Staff During the COVID‐19 Pandemic in Sweden—An Observational Study

Acta Anaesthesiologica Scandinavica, Volume 69, Issue 6, July 2025.
ABSTRACT Purpose To measure chronic, physiological stress using hair cortisol concentrations (HCC) among ICU staff working during the COVID‐19 pandemic in Sweden, and to evaluate its relationship with perceived stress (PS), anxiety, and depression, and burnout. Materials and Methods HCC was measured in hair samples of 274 individuals.
Henrik Andersson, Tomas Faresjö, Helén Didriksson, Carina Jonsson, Gunilla Gagnö, Michelle S. Chew   +5 more
wiley   +1 more source

Pituitary Pars Intermedia Dysfunction (Equine Cushing's Disease) in an Onager (Equus hemionus onager) [PDF]

, 2009
Alison J. Peel, Tim Bouts, Edmund Flach, Sonja Rivers, Andrew Routh   +4 more
openalex   +1 more source

Morning Salivary Cortisone Versus Serum Cortisol in the Overnight Dexamethasone Suppression Test (ODNST): Evaluation in a Clinical Setting

Clinical Endocrinology, Volume 103, Issue 1, Page 13-20, July 2025.
ABSTRACT Introduction Saliva hormone measurement is increasingly being applied in everyday clinical practice. In relation to salivary cortisone measurement, there is a particular advantage, with minimal chance of cross‐reaction with prescribed glucocorticoids and greater convenience.
Mathilde Mordaunt, Adrian Heald, Waseem Majeed, Rupinder Kochhar, Akheel Syed, Rajshekhar N. Mudaliar, Ramadan Alshames, Fahmy Hanna, David Marshall, Brian Keevil, Anthony A. Fryer   +10 more
wiley   +1 more source

Mineralocorticoid Effects in Cushing's Disease: A Case Report. [PDF]

Cureus
Rodrigues Pereira V, Castro Silva B, Castanheira D, Ferreira G, Almeida R.   +4 more
europepmc   +1 more source

Approach to the Management of Gastrointestinal Manifestations in Patients With Phaeochromocytoma and Paraganglioma

Clinical Endocrinology, Volume 103, Issue 1, Page 21-35, July 2025.
ABSTRACT Objective Managing gastrointestinal symptoms in patients with phaeochromocytoma and paraganglioma (PPGL) is challenging due to the risk of catecholaminergic crisis with many commonly prescribed medications, especially in functional tumours.
Monica Majumder, Cherie Chiang, Grace Kong, Michael Michael, Nirupa Sachithanandan, Emma Boehm   +5 more
wiley   +1 more source

An overview of insulin therapy for the non‐specialist

Diabetes, Obesity and Metabolism, Volume 27, Issue S5, Page 3-15, July 2025.
Abstract Nearly all health professionals, whatever their practice or speciality, now have contact with a significant number of insulin‐using people with diabetes. People with type 1 diabetes are nearly universally managed on more complex insulin regimens, increasingly with complex support technology, and with some understanding of the concepts ...
Philip D. Home
wiley   +1 more source

Diagnosis and Treatment of Cushing's Disease

, 2001
Akira Teramoto
openalex   +1 more source

The impact of prolonged high-concentration cortisol exposure on cognitive function and risk factors: Evidence from Cushing's disease patients. [PDF]

J Alzheimers Dis Rep
Sun Y, Xu J, Zheng X, Li C, Kong D, Wu Q, Zhu Z, Feng S, Zhang Y.   +8 more
europepmc   +1 more source